Direct transcriptional effects of apolipoprotein E

Journal of Neuroscience

Volumn 36, Issue 3, 2016, Pages 685-700

  Theendakara, Veena ^a   Peters Libeu, Clare A ^a   Spilman, Patricia ^a,b   Poksay, Karen S ^a   Bredesen, Dale E ^a,b   Rao, Rammohan V ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Activity dependent neuroprotective protein; Alzheimer s disease; Amyloid precursor protein; Apolipoprotein E; MAP kinaseactivating death domain; Sirtuin

Indexed keywords

ADAM10 ENDOPEPTIDASE; APOLIPOPROTEIN E4; DOUBLE STRANDED DNA; INTERLEUKIN 6; INTERLEUKIN 8; SIRTUIN 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR 1; UPSTREAM STIMULATORY FACTOR 1; PROTEIN BINDING;

ADULT; AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SURFACE PLASMON RESONANCE; WESTERN BLOTTING; AGED; ANIMAL; BRAIN; FIBROBLAST; GENETICS; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NERVE CELL; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE;

AGED; ANIMALS; APOLIPOPROTEIN E4; BASE SEQUENCE; BRAIN; CELL LINE, TUMOR; FEMALE; FIBROBLASTS; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEURONS; PROTEIN BINDING; TRANSCRIPTION, GENETIC;

EID: 84955121156     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3562-15.2016     Document Type: Article

References (54)

1. Arold S, Sullivan P, Bilousova T, Teng E, Miller CA, Poon WW, Vinters HV, Cornwell LB, Saing T, Cole GM, Gylys KH (2012) Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer’s disease and apoE TR mouse cortex. Acta Neuropathol 123: 39-52. CrossRef Medline
2. Ashford JW, Mortimer JA (2002) Non-familial Alzheimer’s disease is mainly due to genetic factors. J Alzheimers Dis 4:169-177. Medline
3. Bredesen DE (2009) Neurodegeneration in Alzheimer’s disease: caspases and synaptic element interdependence. Mol Neurodegener 4:27. CrossRef Medline
4. Bredesen DE, John V (2013) Next generation therapeutics for Alzheimer’s disease. EMBO Mol Med 5:795-798. CrossRef Medline
5. Bretsky PM, Buckwalter JG, Seeman TE, Miller CA, Poirier J, Schellenberg GD, Finch CE, Henderson VW (1999) Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord 13:216-221. CrossRef Medline
6. Cash JG, Kuhel DG, Basford JE, Jaeschke A, Chatterjee TK, Weintraub NL, Hui DY (2012) Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress. J Biol Chem 287:27876-27884. CrossRef Medline
7. Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, Mucke L, Gan L (2005a) SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 280:40364-40374. CrossRef Medline
8. Chen YC, Pohl G, Wang TL, Morin PJ, Risberg B, Kristensen GB, Yu A, Davidson B, Shih IeM (2005b) Apolipoprotein E is required for cell proliferation and survival in ovarian cancer. Cancer Res 65:331-337. Medline
9. Danielsson B, Ekman R, Johansson BG, Nilsson-Ehle P, Petersson BG (1978) Isolation of a high density lipoprotein with high contents of arginine-rich apoprotein (apoE) from rat plasma. FEBS Lett 86:299-302. CrossRef Medline
10. de Bie P, van de Sluis B, Burstein E, Duran KJ, Berger R, Duckett CS, Wijmenga C, Klomp LW (2006) Characterization of COMMD proteinprotein interactions in NF-kappaB signalling. Biochem J 398:63-71. CrossRef Medline
11. Del Villar K, Miller CA (2004) Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer’s disease brain and hippocampal neurons. Proc Natl Acad Sci U S A 101:4210-4215. CrossRef Medline
12. Do Carmo S, Séguin D, Milne R, Rassart E (2002) Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem 277:5514-5523. CrossRef Medline
13. Donmez G (2013) Sirtuins as possible targets in neurodegenerative diseases. Curr Drug Targets 14:644-647. CrossRef Medline
14. Drori A, Misaghi S, Haimovich J, Messerle M, Tirosh B (2010) Prolonged endoplasmic reticulum stress promotes mislocalization of immunoglobulins to the cytoplasm. Mol Immunol 47:1719-1727. CrossRef Medline
15. Du Y, Bales KR, Dodel RC, Liu X, Glinn MA, Horn JW, Little SP, Paul SM (1998) Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J Neurochem 70:1182-1188. Medline
16. Fernandez-Montesinos R, Torres M, Baglietto-Vargas D, Gutierrez A, Gozes I, Vitorica J, Pozo D (2010) Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer’s disease. J Mol Neurosci 41:114-120. CrossRef Medline
17. Finch CE (2010) Evolution in health and medicine Sackler colloquium: Evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition. Proc Natl Acad Sci U S A 107 [Suppl 1]: 1718-1724. CrossRef
18. Finch CE, Morgan TE (2007) Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. Curr Alzheimer Res 4:185-189. CrossRef Medline
19. Hatters DM, Peters-Libeu CA, Weisgraber KH (2006) Apolipoprotein E structure: insights into function. Trends Biochem Sci 31:445-454. CrossRef Medline
20. Herskovits AZ, Guarente L (2014) SIRT1 in neurodevelopment and brain senescence. Neuron 81:471-483. CrossRef Medline
21. Holtzman DM, Bales KR, Wu S, Bhat P, Parsadanian M, Fagan AM, Chang LK, Sun Y, Paul SM (1999) Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer’s disease. J Clin Invest 103:R15-R21. CrossRef Medline
22. Hwang JW, Yao H, Caito S, Sundar IK, Rahman I (2013) Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radic Biol Med 61:95-110. CrossRef Medline
23. Isotalo K, Kok EH, Luoto TM, Haikonen S, Haapasalo H, Lehtimäki T, Karhunen PJ (2012) Upstream transcription factor 1 (USF1) polymorphisms associate with Alzheimer’s disease-related neuropathological lesions: Tampere Autopsy Study. Brain Pathol 22:765-775. CrossRef Medline
24. Jantz D, Berg JM (2010) Probing the DNA-binding affinity and specificity of designed zinc finger proteins. Biophys J 98:852-860. CrossRef Medline
25. Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A (2013) Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 25:1939-1948. CrossRef Medline
26. Kawahara K, Suenobu M, Ohtsuka H, Kuniyasu A, Sugimoto Y, Nakagomi M, Fukasawa H, Shudo K, Nakayama H (2014) Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer’s disease. J Alzheimers Dis 42:587-605. CrossRef Medline
27. Kim JW, Jang SM, Kim CH, An JH, Kang EJ, Choi KH (2012) New molecular bridge between RelA/p65 and NF-kappaB target genes via histone acetyltransferase TIP60 cofactor. J Biol Chem 287:7780-7791. CrossRef Medline
28. Kim WS, Elliott DA, Kockx M, Kritharides L, Rye KA, Jans DA, Garner B (2008) Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches. Biochem J 409:701-709. CrossRef Medline
29. Law IK, Liu L, Xu A, Lam KS, Vanhoutte PM, Che CM, Leung PT, Wang Y (2009) Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins. Proteomics 9:2444-2456. CrossRef Medline
30. Lee HR, Shin HK, Park SY, Kim HY, Lee WS, Rhim BY, Hong KW, Kim CD (2014) Cilostazol suppresses _-amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1-coupled retinoic acid receptor. J Neurosci Res 92:1581-1590. CrossRef Medline
31. Levros LC Jr, Labrie M, Charfi C, Rassart E (2013) Binding and repressive activities of apolipoprotein E3 and E4 isoforms on the human ApoD promoter. Mol Neurobiol 48:669-680. CrossRef Medline
32. Mahley RW, Weisgraber KH, Huang Y (2006) Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer’s disease. Proc Natl Acad Sci U S A 103:5644-5651. CrossRef Medline
33. Majka J, Speck C (2007) Analysis of protein-DNA interactions using surface plasmon resonance. Adv Biochem Eng Biotechnol 104:13-36. Medline
34. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A 90:10193-10197. CrossRef Medline
35. Miesbauer M, Rambold AS, Winklhofer KF, Tatzelt J (2010) Targeting of the prion protein to the cytosol: mechanisms and consequences. Curr Issues Mol Biol 12:109-118. Medline
36. Panin LE, Russkikh GS, Polyakov LM (2000) Detection of apolipoprotein A-I, B, and E immunoreactivity in the nuclei of various rat tissue cells. Biochemistry 65:1419-1423. CrossRef Medline
37. Perugini MA, Schuck P, Howlett GJ (2000) Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid. J Biol Chem 275:36758-36765. CrossRef Medline
38. Peters-Libeu CA, Newhouse Y, Hatters DM, Weisgraber KH (2006) Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J Biol Chem 281:1073-1079. CrossRef Medline
39. Poksay KS, Madden DT, Peter AK, Niazi K, Banwait S, Crippen D, Bredesen DE, Rao RV (2011) Valosin-containing protein gene mutations: cellular phenotypes relevant to neurodegeneration. J Mol Neurosci 44:91-102. CrossRef Medline
40. Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve AA, Pasinetti GM (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281:21745-21754. CrossRef Medline
41. Quintana FJ, Zaltzman R, Fernandez-Montesinos R, Herrera JL, Gozes I, Cohen IR, Pozo D (2006) NAP, a peptide derived from the activitydependent neuroprotective protein, modulates macrophage function. Ann N Y Acad Sci 1070:500-506. CrossRef Medline
42. Rao RV, Bredesen DE (2004) Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr Opin Cell Biol 16:653-662. CrossRef Medline
43. Rao RV, Poksay KS, Castro-Obregon S, Schilling B, Row RH, del Rio G, Gibson BW, Ellerby HM, Bredesen DE (2004) Molecular components of a cell death pathway activated by endoplasmic reticulum stress. J Biol Chem 279:177-187. CrossRef Medline
44. Refolo LM, Fillit HM (2004) Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer’s disease. J Mol Neurosci 23:151-155. CrossRef Medline
45. Rohs R, Jin X, West SM, Joshi R, Honig B, Mann RS (2010) Origins of specificity in protein-DNA recognition. Annu Rev Biochem 79:233-269. CrossRef Medline
46. Roses AD (1996) Apolipoprotein E and Alzheimer’s disease. A rapidly expanding field with medical and epidemiological consequences. Ann N Y Acad Sci 802:50-57. CrossRef Medline
47. Simpson JE, Ince PG, Shaw PJ, Heath PR, Raman R, Garwood CJ, Gelsthorpe C, Baxter L, Forster G, Matthews FE, Brayne C, Wharton SB; MRC Cognitive Function and Ageing Neuropathology Study G (2011) Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer’s pathology and APOE genotype. Neurobiol Aging 32:1795-1807. CrossRef Medline
48. Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 272: 17972-17980. CrossRef Medline
49. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM (2002) Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J Neurosci Res 68:331-336. CrossRef Medline
50. Theendakara V, Patent A, Peters Libeu CA, Philpot B, Flores S, Descamps O, Poksay KS, Zhang Q, Cailing G, Hart M, John V, Rao RV, Bredesen DE (2013) Neuroprotective sirtuin ratio reversed by ApoE4. Proc Natl Acad Sci U S A 110:18303-18308. CrossRef Medline
51. Venanzoni MC, Giunta S, Muraro GB, Storari L, Crescini C, Mazzucchelli R, Montironi R, Seth A (2003) Apolipoprotein E expression in localized prostate cancers. Int J Oncol 22:779-786. CrossRef Medline
52. Wang M, Kaufman RJ (2014) The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer 14:581-597. CrossRef Medline
53. Xu PT, Schmechel D, Rothrock-Christian T, Burkhart DS, Qiu HL, Popko B, Sullivan P, Maeda N, Saunders AM, Roses AD, Gilbert JR (1996) Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol Dis 3:229-245. CrossRef Medline
54. Zhong N, Ramaswamy G, Weisgraber KH (2009) Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function. J Biol Chem 284:27273-27280. CrossRef Medline